Cronkhite-Canada Syndrome: A Case Report.

Area of Science:

• Gastroenterology
• Rare Diseases
• Clinical Case Reports

Background:

• Cronkhite-Canada Syndrome (CCS) is a rare disorder characterized by gastrointestinal polyposis, abdominal pain, diarrhea, hyperpigmentation, alopecia, and onychodystrophy.
• The exact etiology of CCS remains unclear, but it is associated with various gastrointestinal and systemic manifestations.

Observation:

• A 40-year-old female presented with diffuse abdominal pain, bloody stools, diarrhea, tenesmus, nausea, appetite loss, and significant weight reduction.
• Clinical examination revealed alopecia, onychodystrophy, and characteristic skin and mucosal hyperpigmentation.
• Histopathological examination of gastric and colonic biopsies showed polypoid edematous mucosa and inflammatory changes.

Findings:

• The patient was diagnosed with Cronkhite-Canada Syndrome and co-infected with Entamoeba histolytica and COVID-19.
• Initial treatment with antibiotics and nutritional support provided symptomatic relief.
• A significant improvement in symptoms was observed after a 4-week course of corticosteroids.

Implications:

• This case highlights the importance of a multidisciplinary approach in managing Cronkhite-Canada Syndrome.
• Corticosteroids appear to be a crucial component in alleviating symptoms of CCS.
• Addressing co-infections and providing nutritional counseling are essential adjuncts to treatment.